Victor Enrique Sarmiento-Ortega

Dr. Victor Enrique Sarmiento-Ortega


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino

6 August 2024 in Biological Trace Element Research
Verified
Journal Article
Open access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino
Cadmium (Cd) is a global pollutant, and its accumulation in the liver causes oxidative stress, inflammation, insulin resistance (IR), and metabolic complications. This study investigated whether curcumin treatment could alleviate hepatic IR in Wistar rats exposed to sub-chronic cadmium and explored the underlying molecular pathways. Male Wistar rats were divided into a control group (standard normocaloric diet + cadmium-free water) and a cadmium group (standard normocaloric diet + drinking water with 32.5 ppm CdCl2) for 30 days. Oral glucose tolerance, insulin response, and IR were assessed using mathematical models. Liver tissue was analyzed for markers of oxidative stress, inflammation, and key regulatory pathways, including NF-κB, Nrf2, MAPKs (JNK and p38), and the IRS1-Akt pathway. We established an effective curcumin dose of 250 mg/kg for 5 days orally. Results demonstrated that after 30 days of exposure, cadmium accumulated in the liver, inducing an oxidative and inflammatory state. This was characterized by increased expression of NF-κB, JNK, and p38, along with diminished Nrf2 expression, hepatic IR, hyperglycemia, and hyperinsulinemia. Curcumin treatment effectively alleviated these metabolic disorders by restoring the balance between NF-κB and Nrf2 in the liver, modulating the MAPK pathway, and, consequently, improving oxidative and inflammatory balance. In conclusion, this study suggests that cadmium induces hepatic IR through an imbalance between NF-κB and Nrf2 signaling pathways. Curcumin treatment appears to improve these pathways, thereby ameliorating hepatic IR.

8 November 2022 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino


13 November 2023 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
DMDiana Moroni
Diana Moroni
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino

18 April 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
MGMiguel Ángel García-González
Miguel Ángel García-González
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino
Metabolic diseases are a worldwide health problem. Insulin resistance (IR) is their distinctive hallmark. For their study, animal models that provide reliable information are necessary, permitting the analysis of the cluster of abnormalities that conform to it, its progression, and time-dependent molecular modifications. We aimed to develop an IR model by exogenous insulin administration. The effective dose of insulin glargine to generate hyperinsulinemia but without hypoglycemia was established. Then, two groups (control and insulin) of male Wistar rats of 100 g weight were formed. The selected dose (4 U/kg) was administered for 15, 30, 45, and 60 days. Zoometry, a glucose tolerance test, insulin response, IR, and the serum lipid profile were assessed. We evaluated insulin signaling, glycogenesis and lipogenesis, redox balance, and inflammation in the liver. Results showed an impairment of glucose tolerance, dyslipidemia, hyperinsulinemia, and peripheral and time-dependent selective IR. At the hepatic level, insulin signaling was impaired, resulting in reduced hepatic glycogen levels and triglyceride accumulation, an increase in the ROS level with MAPK-ERK1/2 response, and mild pro-oxidative microenvironmental sustained by MT, GSH, and GR activity. Hepatic IR coincides with additions in MAPK-p38, NF-κB, and zoometric changes. In conclusion, daily insulin glargine administration generated a progressive IR model. At the hepatic level, the IR was combined with oxidative conditions but without inflammation.